Beckman Coulter s Q1 Sales Down Due to Currency Effects | GenomeWeb

 

NEW YORK, April 30 – Beckman Coulter’s first quarter revenues slipped 0.4 percent to $432.7 million, compared with $434.4 million a year ago, due to unfavorable exchange rates.

On a constant currency basis, sales rose 6.5 percent, said the Fullerton, Calif.-based maker of automation systems for the life sciences, adding that demand for its systems remained strong.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.